Sensus Healthcare issues letter to stockholders
BOCA RATON, Fla., April 24, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announces that Joe Sardano, chairman and chief executive officer issued today the following letter to stockholders: Dear Fellow Stockholder: Our first annual stockholders’ […]
Sensus Healthcare issues letter to stockholders
BOCA RATON, Fla., April 24, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announces that Joe Sardano, chairman and chief executive officer issued today the following letter to stockholders: Dear Fellow Stockholder: Our first annual stockholders’ […]
Sensus Healthcare to Present at the 29th Annual ROTH Conference
BOCA RATON, Fla., March 7, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced that Joe Sardano, the Company’s chief executive officer, will present a corporate overview at the 29th Annual ROTH Conference on Wednesday, […]
Sensus Healthcare to Present at the 29th Annual ROTH Conference
BOCA RATON, Fla., March 7, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced that Joe Sardano, the Company’s chief executive officer, will present a corporate overview at the 29th Annual ROTH Conference on Wednesday, […]
Sensus Healthcare to Participate in 2017 South Beach Symposium on February 9 – 12 in Miami
— Joe Sardano, Sensus Healthcare CEO, to Participate in CEO Forum on February 11 — Sensus Healthcare Medical Advisory Board Members to Host SRT Workshops on February 9 BOCA RATON, Fla., Feb. 7, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin […]
Sensus Healthcare to Participate in 2017 South Beach Symposium on February 9 – 12 in Miami
— Joe Sardano, Sensus Healthcare CEO, to Participate in CEO Forum on February 11 — Sensus Healthcare Medical Advisory Board Members to Host SRT Workshops on February 9 BOCA RATON, Fla., Feb. 7, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin […]
Sensus Healthcare Reports Fourth Quarter and Full Year 2016 Results
– Record Quarterly Revenues of $4.9 million in Fourth Quarter – Full Year 2016 revenues increased 44% year-over-year to $14.8 million – Worldwide installed base increased to 271 units BOCA RATON, Fla., Feb. 2, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other […]
Sensus Healthcare Reports Fourth Quarter and Full Year 2016 Results
– Record Quarterly Revenues of $4.9 million in Fourth Quarter – Full Year 2016 revenues increased 44% year-over-year to $14.8 million – Worldwide installed base increased to 271 units BOCA RATON, Fla., Feb. 2, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other […]
Sensus Healthcare to Announce Fourth Quarter and Full Year 2016 Results on February 2, 2017
BOCA RATON, Fla., Jan. 19, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its fourth quarter and full year 2016 financial results on Thursday, February 2, 2017 […]
Sensus Healthcare to Announce Fourth Quarter and Full Year 2016 Results on February 2, 2017
BOCA RATON, Fla., Jan. 19, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its fourth quarter and full year 2016 financial results on Thursday, February 2, 2017 […]
